Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Bolt Biotherapeutics Inc (NQ: BOLT ) 0.7383 +0.0033 (+0.45%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 2, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Bolt Biotherapeutics Inc < Previous 1 2 3 4 Next > Bolt Biotherapeutics Announces Positive Topline Data from BDC-1001 Phase 1 Dose-Escalation Trial in HER2-Expressing Tumors, Supporting Advancement to Phase 2 Clinical Studies March 29, 2023 From Bolt Biotherapeutics, Inc. Via GlobeNewswire Bolt Biotherapeutics to Present Preclinical Data for BDC-3042, a Dectin-2-Targeting Agonistic Antibody, at 2023 AACR Annual Meeting March 14, 2023 From Bolt Biotherapeutics, Inc. Via GlobeNewswire Bolt Biotherapeutics to Present at Cowen 43rd Annual Healthcare Conference February 28, 2023 From Bolt Biotherapeutics, Inc. Via GlobeNewswire Stocks That Hit 52-Week Lows On Friday April 08, 2022 During Friday's morning session, 234 stocks hit new 52-week lows. Interesting Facts About Today's 52-Week Lows: The largest company in terms of market cap... Via Benzinga Bolt Biotherapeutics to Present at February Investor Conferences February 01, 2023 From Bolt Biotherapeutics, Inc. Via GlobeNewswire Bolt Biotherapeutics Appoints Laura Berner to Board of Directors December 14, 2022 From Bolt Biotherapeutics, Inc. Via GlobeNewswire Bolt Biotherapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update November 10, 2022 From Bolt Biotherapeutics, Inc. Via GlobeNewswire Bolt Biotherapeutics to Present Preclinical Data on BDC-3042, Dectin-2 Targeting Agonistic Antibody, at the SITC Annual Meeting November 07, 2022 From Bolt Biotherapeutics, Inc. Via GlobeNewswire Bolt Biotherapeutics to Present at Stifel 2022 Healthcare Conference November 01, 2022 From Bolt Biotherapeutics, Inc. Via GlobeNewswire Benzinga's Top Ratings Upgrades, Downgrades For August 11, 2022 August 11, 2022 Via Benzinga SVB Leerink Cuts Price Target On This Stock By 50%, Also Check Out Some Other Major PT Changes August 11, 2022 SVB Leerink cut the price target on Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) from $8 to $4. SVB Leerink analyst Daina Graybosch downgraded the stock from Outperform to Market Perform. Bolt... Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session July 20, 2022 Gainers NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares increased by 15.1% to $0.63 during Wednesday's after-market session. The company's market cap stands at $16.7 million. Via Benzinga This Low-Float Stock Jumps Around 148%; Here's 64 Biggest Movers From Yesterday July 08, 2022 Gainers United Maritime Corporation (NASDAQ: USEA) climbed 147.6% to close at $7.08 on Thursday on heavy momentum following the company's recent listing on the Nasdaq Capital Market. Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session July 07, 2022 Via Benzinga Bolt Biotherapeutics's Return On Capital Employed Overview March 31, 2022 Bolt Biotherapeutics (NASDAQ:BOLT) brought in sales totaling $508.00 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 16.08%, resulting in a loss of $27.16... Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session February 28, 2022 Gainers Soleno Therapeutics (NASDAQ:SLNO) shares rose 15.7% to $0.37 during Monday's pre-market session. The market value of their outstanding shares is at $29.5... Via Benzinga 7 Little-Known Penny Stocks That Could Take Off Any Moment January 27, 2022 Penny stocks are incredibly risky and should only be considered with speculation funds. Still, these names could swing higher for investors. Via InvestorPlace Mid-Afternoon Market Update: Dow Jumps 700 Points; Del Taco Restaurants Shares Spike Higher December 06, 2021 Toward the end of trading Monday, the Dow traded up 2.11% to 35,308.84 while the NASDAQ rose 1.24% to 15,272.25. The S&P also rose, gaining 1.51% to 4,607.08. The U.S. has the... Via Benzinga Topics Stocks Exposures US Equities Stocks That Hit 52-Week Lows On Wednesday April 20, 2022 On Wednesday, 160 companies hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: Walt Disney (NYSE:DIS) was the largest firm by market cap to set a new... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2022 January 06, 2022 Upgrades For Canada Goose Holdings Inc (NYSE: Via Benzinga 60 Biggest Movers From Yesterday December 07, 2021 Gainers Insignia Systems, Inc. (NASDAQ: ISIG) shares jumped 200.4% to close at $15.05 on Monday after the company announced the commencement of a formal process to explore... Via Benzinga Mid-Day Market Update: Crude Oil Rises 3%; Aeglea BioTherapeutics Shares Plunge December 06, 2021 Midway through trading Monday, the Dow traded up 1.94% to 35,251.31 while the NASDAQ rose 0.55% to 15,168.35. The S&P also rose, gaining 1.20% to 4,592.83. The U.S. has the... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities 36 Stocks Moving In Monday's Mid-Day Session December 06, 2021 Gainers Del Taco Restaurants, Inc. (NASDAQ: TACO) shares jumped 64.6% to $12.40. Jack In The Box Inc (NASDAQ: JACK) agreed to acquire Del Taco Restaurants for $12.51 per share... Via Benzinga Dow Extends Rebound as Omicron Fears Subside December 06, 2021 The Dow Jones Industrial Average is gaining even more momentum off this morning's bounce, the S&P 500 is also eyeing a strong rally. The Nasdaq Composite (IXIC), on the other hand, has turned... Via Talk Markets Topics Stocks Exposures US Equities Mid-Morning Market Update: Markets Mostly Higher; Science Applications International Posts Upbeat Earnings December 06, 2021 Following the market opening Monday, the Dow traded up 1.35% to 35,048.01 while the NASDAQ fell 0.17% to 15,059.43. The S&P also rose, gaining 0.59% to 4,565.21. The U.S. has... Via Benzinga Topics Stocks Exposures US Equities Bolt Biotherapeutics Reveals Early Data From BDC-1001 Immuno-Oncology Candidate December 06, 2021 Bolt Biotherapeutics Inc (NASDAQ: BOLT) announced the presentation of interim clinical data from its Phase 1/2 study of BDC-1001. BDC-1001 is an immune-stimulating... Via Benzinga The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More December 06, 2021 The omicron variant concerns were front and center in the markets in the week ended Dec. 3, and biotech stocks did not escape the brunt of selling in the wake of the negative... Via Benzinga Exposures Product Safety The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration August 27, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)... Via Benzinga Topics Intellectual Property Exposures Intellectual Property Innovent Biologics, Bolt Join Forces To Develop Anti-Cancer Candidates August 27, 2021 Innovent Biologics Inc (OTC: IVBIY) and Bolt Biotherapeutics Inc (NASDAQ: BOLT) have entered into a drug research and development collaboration for oncology candidates. The... Via Benzinga 68 Biggest Movers From Yesterday August 10, 2021 Gainers Golden Nugget Online Gaming, Inc. (NASDAQ: GNOG) shares climbed 50.8% to close at $18.50 on Monday after the company and DraftKings announced they entered into a... Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.